MarketPulse

Astria Therapeutics acquisition

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Biocryst Pharmaceuticals, Inc.

BioCryst Names Pharma Veteran Menon as Chief R&D Officer Amid Pipeline Expansion

BioCryst appoints experienced pharma executive Sandeep Menon as Chief R&D Officer, bolstering leadership as it advances navenibart toward FDA approval.
BCRXFDA approvalclinical development
GlobeNewswire Inc.GlobeNewswire Inc.··Na

BioCryst Achieves Historic Profitability as ORLADEYO Revenue Surges 38%

BioCryst achieved historic profitability with ORLADEYO revenue surging 38% to $601.8 million. FDA approval for pediatric formulation and Astria acquisition expand HAE treatment portfolio.
BCRXFDA approvalprofitability